Skip to main
TDOC

Teladoc (TDOC) Stock Forecast & Price Target

Teladoc (TDOC) Analyst Ratings

Based on 18 analyst ratings
Hold
Strong Buy 17%
Buy 11%
Hold 72%
Sell 0%
Strong Sell 0%

Bulls say

Teladoc Health, Inc. has set a strong financial outlook with projected Integrated Care revenue of $1,613.6 million for CY26, reflecting a year-over-year increase of $34.0 million. The company anticipates significant growth in its BetterHelp segment, with insurance revenue expected to rise from $13.0 million in CY25 to between $75.0 million and $90.0 million in CY26, increasing its revenue mix from 1.4% to 9.0%. Additionally, the Integrated Care segment's adjusted EBITDA is anticipated to reach $251.9 million, an increase of $12.6 million year-over-year, highlighting the company's strong position in the virtual healthcare market and its capacity for growth moving forward.

Bears say

The analysis of Teladoc Health Inc reveals a significant decline in the growth trajectory of its BetterHelp segment, with management forecasting low-single-digit growth over the next three years, a stark contrast to prior performance levels. The anticipated reduction in membership and the transition from fee-based to visit-based revenue models within the Integrated Care segment contribute to heightened financial uncertainty, further exacerbated by expected decreases in customer enrollment due to expiring ACA subsidies. Additionally, operational expenditure cuts aimed at maintaining profitability may compromise key functions, diminish the company's value proposition, and weaken pricing power, all of which could hinder future growth prospects.

Teladoc (TDOC) has been analyzed by 18 analysts, with a consensus rating of Hold. 17% of analysts recommend a Strong Buy, 11% recommend Buy, 72% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Teladoc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Teladoc (TDOC) Forecast

Analysts have given Teladoc (TDOC) a Hold based on their latest research and market trends.

According to 18 analysts, Teladoc (TDOC) has a Hold consensus rating as of Mar 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $7.61, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $7.61, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Teladoc (TDOC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.